Follow
Aldy Aliyandi
Aldy Aliyandi
PhD in Nanomedicine, University of Groningen
Verified email at rug.nl - Homepage
Title
Cited by
Cited by
Year
Satrialdi, 2014. Development of transdermal nanoemulsion formulation for simultaneous delivery of protein vaccine and artin-m adjuvant
T Suciati, A Aliyandi
Int. J. Pharm. Pharm. Sci 6 (6), 536-546, 0
41
Effect of the development of a cell barrier on nanoparticle uptake in endothelial cells
V Francia, A Aliyandi, A Salvati
Nanoscale 10 (35), 16645-16656, 2018
252018
Correlating corona composition and cell uptake to identify proteins affecting nanoparticle entry into endothelial cells
A Aliyandi, C Reker-Smit, R Bron, IS Zuhorn, A Salvati
ACS Biomaterials Science & Engineering 7 (12), 5573-5584, 2021
232021
Effect of endothelial cell heterogeneity on nanoparticle uptake
A Aliyandi, S Satchell, RE Unger, B Bartosch, R Parent, IS Zuhorn, ...
International Journal of Pharmaceutics 587, 119699, 2020
182020
Disentangling biomolecular corona interactions with cell receptors and implications for targeting of nanomedicines
A Aliyandi, IS Zuhorn, A Salvati
Frontiers in Bioengineering and Biotechnology 8, 599454, 2020
172020
Cell surface biotinylation to identify the receptors involved in nanoparticle uptake into endothelial cells
A Aliyandi, C Reker-Smit, IS Zuhorn, A Salvati
Acta Biomaterialia 155, 507-520, 2023
22023
DNAJB6-Containing Extracellular Vesicles as Chaperone Delivery Systems: A Proteomic Analysis
BS Joshi, H Garcia Romeu, A Aliyandi, MP de Vries, IS Zuhorn
Pharmaceutics 14 (11), 2485, 2022
12022
Exploiting the Protein Corona to Identify Receptors for Targeting of Nanocarriers
A Aliyandi, IS Zuhorn, A Salvati
Exploiting the Biomolecular Corona of Nanocarriers for Targeted Drug …, 2020
12020
DNAJB6-Containing Extracellular Vesicles as Chaperone Delivery Systems: A Proteomic Analysis. Pharmaceutics 2022, 14, 2485
BS Joshi, H Garcia Romeu, A Aliyandi, MP de Vries, IS Zuhorn
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022
2022
Exploiting the Biomolecular Corona of Nanocarriers for Targeted Drug Delivery to Endothelial Cells
A Aliyandi
2020
The system can't perform the operation now. Try again later.
Articles 1–10